Aclaris therapeutics to participate in the h.c. wainwright autoimmune & inflammatory disease virtual conference

Wayne, pa., march 27, 2023 (globe newswire) -- aclaris therapeutics, inc. (nasdaq: acrs), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced that members of the aclaris management team will participate in a fireside chat during the h.c. wainwright autoimmune & inflammatory disease virtual conference on thursday, march 30, 2023 at 1:00 pm et.
ACRS Ratings Summary
ACRS Quant Ranking